Assyro AI

Orange Book product · Brand (NDA)

GANZYK-RTU

GANCICLOVIR

Brand (NDA)NDA 209347DISCN EXELA PHARMA

At a glance

Feb 17, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 17, 2017

    9 yr 6 mo ago

  2. Today

  3. Patent 9486530 expires

    Listed drug product patent expiration.

    Sep 02, 2034

    in 8 yr 4 mo

Pharmaceutical detail

Active ingredient

GANCICLOVIR

Strength

500MG/250ML (2MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 209347

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9486530Sep 02, 2034in 8 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.